Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Post by Vic_Moneyon Nov 24, 2009 12:50pm
496 Views
Post# 16518482

2010 will be an equally bad year for NRI sharehold

2010 will be an equally bad year for NRI shareholdFrom what I've been reading, many people are expecting the stock to be much higher in 2010 after a few quarters of earnings.  I will go on the record to say that in a year from now, the majority of shareholders will still be disappointed with the share price.   Even with a few quarters of sales in the US, I would not count on the stock going up considerably.  There are many stocks that have shown increased earnings, but little to no share price appreciation, so NRI is not guaranteed to do well even in 2010 as earnings come in.  NRI stock has a very poor reputation amongst the majority of investors and Analysts.   Even if it has a boost in earnings in 2010, I don't think that will be enough to lift this stock.  Earnings alone don't move a companies share price up, so don't expect 2010 to be the year in which shareholders will be rewarded, as the companys reputation may significantly curb any share price appreciation, and market manipulators will take care of the rest. 
Bullboard Posts